Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Expression of Lamin A/C in early-stage breast cancer and its prognostic value.

Alhudiri IM, Nolan CC, Ellis IO, Elzagheid A, Rakha EA, Green AR, Chapman CJ.

Breast Cancer Res Treat. 2019 Jan 4. doi: 10.1007/s10549-018-05092-w. [Epub ahead of print]

PMID:
30610489
2.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Maddison P, Titulaer MJ, Verschuuren JJ, Gozzard P, Lang B, Irani SR, Sabater L, Graus F, Murray A, Chapman CJ.

J Neuroimmunol. 2019 Jan 15;326:14-18. doi: 10.1016/j.jneuroim.2018.11.003. Epub 2018 Nov 8.

PMID:
30445363
3.

Could stool collection devices help increase uptake in bowel cancer screening programmes?

Morling JR, Barke AN, Chapman CJ, Logan RF.

J Med Screen. 2018 Dec;25(4):174-177. doi: 10.1177/0969141317753463. Epub 2018 Feb 5.

PMID:
29402168
4.

Autoantibodies: Opportunities for Early Cancer Detection.

Macdonald IK, Parsy-Kowalska CB, Chapman CJ.

Trends Cancer. 2017 Mar;3(3):198-213. doi: 10.1016/j.trecan.2017.02.003. Epub 2017 Mar 6. Review.

PMID:
28718432
5.

A class of reduced-order models in the theory of waves and stability.

Chapman CJ, Sorokin SV.

Proc Math Phys Eng Sci. 2016 Feb;472(2186):20150703.

6.

Qualitative research in healthcare: an introduction to grounded theory using thematic analysis.

Chapman AL, Hadfield M, Chapman CJ.

J R Coll Physicians Edinb. 2015;45(3):201-5. doi: 10.4997/JRCPE.2015.305. Review.

PMID:
26517098
7.

Serum autoantibody measurement for the detection of hepatocellular carcinoma.

Middleton CH, Irving W, Robertson JF, Murray A, Parsy-Kowalska CB, Macdonald IK, McElveen J, Allen J, Healey GF, Thomson BJ, Ryder SJ, Holdenrieder S, Chapman CJ.

PLoS One. 2014 Aug 5;9(8):e103867. doi: 10.1371/journal.pone.0103867. eCollection 2014.

8.

Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.

Dohle W, Leese MP, Jourdan FL, Chapman CJ, Hamel E, Ferrandis E, Potter BV.

ChemMedChem. 2014 Aug;9(8):1783-93. doi: 10.1002/cmdc.201402025. Epub 2014 May 12.

9.

Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.

Macdonald IK, Murray A, Healey GF, Parsy-Kowalska CB, Allen J, McElveen J, Robertson C, Sewell HF, Chapman CJ, Robertson JF.

PLoS One. 2012;7(12):e51002. doi: 10.1371/journal.pone.0051002. Epub 2012 Dec 13.

10.

Development and validation of a high throughput system for discovery of antigens for autoantibody detection.

Macdonald IK, Allen J, Murray A, Parsy-Kowalska CB, Healey GF, Chapman CJ, Sewell HF, Robertson JF.

PLoS One. 2012;7(7):e40759. doi: 10.1371/journal.pone.0040759. Epub 2012 Jul 18.

11.

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.

Chapman CJ, Healey GF, Murray A, Boyle P, Robertson C, Peek LJ, Allen J, Thorpe AJ, Hamilton-Fairley G, Parsy-Kowalska CB, MacDonald IK, Jewell W, Maddison P, Robertson JF.

Tumour Biol. 2012 Oct;33(5):1319-26. doi: 10.1007/s13277-012-0379-2. Epub 2012 Apr 11.

12.

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.

Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF.

Cancer Prev Res (Phila). 2011 Jul;4(7):1126-34. doi: 10.1158/1940-6207.CAPR-10-0328.

13.

Immunobiomarkers in small cell lung cancer: potential early cancer signals.

Chapman CJ, Thorpe AJ, Murray A, Parsy-Kowalska CB, Allen J, Stafford KM, Chauhan AS, Kite TA, Maddison P, Robertson JF.

Clin Cancer Res. 2011 Mar 15;17(6):1474-80. doi: 10.1158/1078-0432.CCR-10-1363. Epub 2010 Dec 7.

14.

Clinical validation of an autoantibody test for lung cancer.

Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, Maddison P, Healey G, Fairley GH, Barnes AC, Robertson JF.

Ann Oncol. 2011 Feb;22(2):383-9. doi: 10.1093/annonc/mdq361. Epub 2010 Jul 30.

15.

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.

Maddison P, Thorpe A, Silcocks P, Robertson JF, Chapman CJ.

Lung Cancer. 2010 Dec;70(3):335-9. doi: 10.1016/j.lungcan.2010.03.002. Epub 2010 Apr 3.

PMID:
20371131
16.

Technical validation of an autoantibody test for lung cancer.

Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, Barnes A, Sewell HF, Fritsche HA, Robertson JF.

Ann Oncol. 2010 Aug;21(8):1687-93. doi: 10.1093/annonc/mdp606. Epub 2010 Feb 2.

17.

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, Rudd PM.

Glycobiology. 2008 Dec;18(12):1105-18. doi: 10.1093/glycob/cwn095. Epub 2008 Sep 25.

PMID:
18818422
18.

Lung cancer - can autoantibodies provide an aid to diagnosis?

Woodard KM, Chapman CJ.

Expert Opin Med Diagn. 2008 Aug;2(8):911-23. doi: 10.1517/17530059.2.8.911.

PMID:
23495865
19.

BINOL-3,3'-triflone N,N-dimethyl phosphoramidites: through-space 19F,31P spin-spin coupling with a remarkable dependency on temperature and solvent internal pressure.

Kruck M, Munoz MP, Bishop HL, Frost CG, Chapman CJ, Kociok-Köhn G, Butts CP, Lloyd-Jones GC.

Chemistry. 2008;14(26):7808-12. doi: 10.1002/chem.200800825.

PMID:
18642261
20.

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.

Storr SJ, Royle L, Chapman CJ, Hamid UM, Robertson JF, Murray A, Dwek RA, Rudd PM.

Glycobiology. 2008 Jun;18(6):456-62. doi: 10.1093/glycob/cwn022. Epub 2008 Mar 10.

PMID:
18332077
21.

Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.

Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC, Robertson JF.

Thorax. 2008 Mar;63(3):228-33. Epub 2007 Oct 11. Erratum in: Thorax. 2008 Apr;63(4):385.

PMID:
17932110
22.

Site-selective modification of peptides using rhodium and palladium catalysis: complementary electrophilic and nucleophilic arylation.

Chapman CJ, Matsuno A, Frost CG, Willis MC.

Chem Commun (Camb). 2007 Oct 14;(38):3903-5. Epub 2007 Aug 15.

PMID:
17896027
23.

Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography.

Parsy CB, Chapman CJ, Barnes AC, Robertson JF, Murray A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):314-9. Epub 2007 Apr 8.

PMID:
17459787
24.

Use of autoantibodies in breast cancer screening and diagnosis.

Storr SJ, Chakrabarti J, Barnes A, Murray A, Chapman CJ, Robertson JF.

Expert Rev Anticancer Ther. 2006 Aug;6(8):1215-23. Review.

PMID:
16925487
25.

Structure and reactivity of new phosphine ligands containing the hemi-labile sulfone moiety.

Chapman CJ, Frost CG, Mahon MF.

Dalton Trans. 2006 May 14;(18):2251-62. Epub 2006 Feb 9.

PMID:
16673040
26.

Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats.

Hamidinia SA, Erdahl WL, Chapman CJ, Steinbaugh GE, Taylor RW, Pfeiffer DR.

Environ Health Perspect. 2006 Apr;114(4):484-93.

27.

Malignancy-induced autoimmunity to MUC1: initial antibody characterization.

Graves CR, Robertson JF, Murray A, Price MR, Chapman CJ.

J Pept Res. 2005 Dec;66(6):357-63.

PMID:
16316451
28.

The ionophore nigericin transports Pb2+ with high activity and selectivity: a comparison to monensin and ionomycin.

Hamidinia SA, Tan B, Erdahl WL, Chapman CJ, Taylor RW, Pfeiffer DR.

Biochemistry. 2004 Dec 21;43(50):15956-65.

PMID:
15595852
29.

Application of phosphine-oxazoline ligands in Ir-catalyzed asymmetric hydrogenation of acyclic aromatic N-arylimines.

Trifonova A, Diesen JS, Chapman CJ, Andersson PG.

Org Lett. 2004 Oct 14;6(21):3825-7.

PMID:
15469359
30.

Rhodium catalysed tandem conjugate addition-protonation: an enantioselective synthesis of 2-substituted succinic esters.

Moss RJ, Wadsworth KJ, Chapman CJ, Frost CG.

Chem Commun (Camb). 2004 Sep 7;(17):1984-5. Epub 2004 Jul 8.

PMID:
15340633
31.

Monensin mediates a rapid and selective transport of Pb(2+). Possible application of monensin for the treatment of Pb(2+) intoxication.

Hamidinia SA, Shimelis OI, Tan B, Erdahl WL, Chapman CJ, Renkes GD, Taylor RW, Pfeiffer DR.

J Biol Chem. 2002 Oct 11;277(41):38111-20. Epub 2002 Jun 21.

32.

Transport properties of the calcium ionophore ETH-129.

Wang E, Erdahl WL, Hamidinia SA, Chapman CJ, Taylor RW, Pfeiffer DR.

Biophys J. 2001 Dec;81(6):3275-84.

33.

Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34.

Németh AH, Bochukova E, Dunne E, Huson SM, Elston J, Hannan MA, Jackson M, Chapman CJ, Taylor AM.

Am J Hum Genet. 2000 Nov;67(5):1320-6. Epub 2000 Oct 5.

34.

Ionomycin, a carboxylic acid ionophore, transports Pb(2+) with high selectivity.

Erdahl WL, Chapman CJ, Taylor RW, Pfeiffer DR.

J Biol Chem. 2000 Mar 10;275(10):7071-9.

35.

A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1.

Thomas MD, Clough K, Melamed MD, Stevenson FK, Chapman CJ, Spellerberg MB, Potter KN, Newton-Bishop JA, Gregson N, Dawson K.

Hum Antibodies. 1999;9(2):95-106.

PMID:
10405830
36.

V(H) gene analysis of Burkitt's lymphoma in children from north-western Iran.

Chapman CJ, Wright D, Feizi HP, Davis Z, Stevenson FK.

Br J Haematol. 1998 Dec;103(4):1116-23.

PMID:
9886329
37.
38.

Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE).

Mockridge CI, Chapman CJ, Spellerberg MB, Sheth B, Fleming TP, Isenberg DA, Stevenson FK.

Clin Exp Immunol. 1998 Oct;114(1):129-36.

39.

Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis.

Chapman CJ, Wright D, Stevenson FK.

Leuk Lymphoma. 1998 Jul;30(3-4):257-67. Review.

PMID:
9713958
40.

Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis.

Thomson RK, Davis Z, Palmer JM, Arthur MJ, Yeaman SJ, Chapman CJ, Spellerberg MB, Stevenson FK.

J Hepatol. 1998 Apr;28(4):582-94.

PMID:
9566826
41.

Immunogenetic analysis of the heavy chain variable regions of IgE from patients allergic to peanuts.

Janezic A, Chapman CJ, Snow RE, Hourihane JO, Warner JO, Stevenson FK.

J Allergy Clin Immunol. 1998 Mar;101(3):391-6.

PMID:
9525457
42.

Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II.

Bhat NM, Bieber MM, Hsu FJ, Chapman CJ, Spellerberg M, Stevenson FK, Teng NN.

Clin Exp Immunol. 1997 Apr;108(1):151-9.

43.

Phage surface expression for analysis of recognition sites of human autoantibodies: comparison of single chain Fv and Fab.

Chapman CJ, Mockridge CI, Spellerberg MB, Zhu D, Stevenson FK.

Hum Antibodies. 1997;8(3):124-8.

PMID:
9322082
44.

Pattern of usage and somatic hypermutation in the V(H)5 gene segments of a patient with asthma: implications for IgE.

Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK.

Eur J Immunol. 1997 Jan;27(1):162-70.

PMID:
9022013
45.

Cancer families: what risks are they given and do the risks affect management?

Rosser EM, Hurst JA, Chapman CJ.

J Med Genet. 1996 Dec;33(12):977-80.

46.
47.

Ionophore 4-BrA23187 transports Zn2+ and Mn2+ with high selectivity over Ca2+.

Erdahl WL, Chapman CJ, Wang E, Taylor RW, Pfeiffer DR.

Biochemistry. 1996 Oct 29;35(43):13817-25.

PMID:
8901524
48.
49.

On the use of fluorescent probes to estimate free Mg2+ in the matrix of heart mitochondria.

Jung DW, Chapman CJ, Baysal K, Pfeiffer DR, Brierley GP.

Arch Biochem Biophys. 1996 Aug 1;332(1):19-29.

PMID:
8806704
50.

Supplemental Content

Loading ...
Support Center